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Pperative and Late Coronary Artery
ypass Grafting Outcomes in Matched
frican-American Versus Caucasian Patients
vidence of a Late Survival-Medicaid Association
noar Zacharias, MD,*† Thomas A. Schwann, MD,*† Christopher J. Riordan, MD,*†
amuel J. Durham, MD,*† Aamir Shah, MD,*† Robert H. Habib, PHD*‡
oledo, Ohio
OBJECTIVES This study sought to determine whether African-American versus Caucasian race is a
determinant of early or late coronary artery bypass surgery (CABG) outcomes.
BACKGROUND African Americans are referred to CABG less frequently than Caucasians and Medicaid
coverage is disproportionately common among those who are referred. How these factors
affect the relative early and late CABG outcomes in these groups is incompletely elucidated.
METHODS A retrospective cohort comparison of operative and 12-year outcomes for 304 African-
American and 6,073 Caucasian consecutive patients who underwent isolated CABG (1991 to
2003) at an urban community hospital was used. Results were further confirmed in
propensity-matched subgroups (n  301 each).
RESULTS African Americans were younger (62 vs. 64 years, median), more were female (46% vs. 30%),
more were on Medicaid (29% vs. 6.3%) and had more comorbidities. These differences were
eliminated after matching. A total of 161 operative and 1,080 late deaths have been
documented. Operative mortality was similar (African American versus Caucasian: 3.0% vs.
2.5%; p  0.81). Unadjusted Kaplan-Meier survival at 1, 5, and 10 years (93.4%, 80.3%, and
66.1% vs. 94.8%, 86.5%, and 71.7%) was worse in African Americans (hazard ratio [HR] 
1.38; p  0.004), but similar for matched groups (HR  1.03; p  0.97). After risk
adjustment, race did not predict operative (odds ratio  1.17; p  0.69) or late (HR  1.15;
p  0.28) mortality. However, Medicaid status (HR  1.54; p  0.005) predicted worse
survival, which was verified in a case-matched Medicaid (n  469) versus non-Medicaid
analysis. The latter showed that in younger Medicaid patients without companion Medicare
coverage, late mortality was nearly doubled (HR  1.96; p  0.003) with systematically
increasing death hazard after the second year.
CONCLUSIONS African-American race per se is not associated with worse operative or late outcomes
underscoring that CABG should be based on clinical characteristics only. Alternatively,
Medicaid status, which is more prevalent among African Americans, is associated with worse
late survival, especially in non-Medicare patients. Studies are needed to elucidate this late
Medicaid-CABG outcome association. (J Am Coll Cardiol 2005;46:1526–35) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.06.071the American College of Cardiology Foundation
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iumerous studies have reported on variations in the use of
ardiovascular procedures for treatment of coronary artery
isease (CAD) among ethnic groups in the U.S., for
xample, those of Peterson et al. (1), Gillum et al. (2),
cBean et al. (3), and Ayanian et al. (4). These have
enerally shown that minority patients, and African Amer-
cans in particular, are less likely to undergo interventional
ardiac procedures, particularly coronary artery bypass graft
CABG) surgery. Arguably, such underuse or late use of
urgical coronary revascularization may adversely affect pa-
ient outcomes. However, the impact of race on CABG
utcomes is incompletely elucidated with limited long-term
ata. Some studies have suggested worse early (operative)
5,6) and mid-term (7–11) CABG outcomes in African
From the *Division of Cardiovascular Surgery, St. Vincent Mercy Medical Center,
nd the Departments of †Surgery and ‡Medicine, College of Medicine, The Medical
niversity of Ohio, Toledo, Ohio. Supported by institutional and departmental
unds.f
Manuscript received April 5, 2005; revised manuscript received June 21, 2005,
ccepted June 27, 2005.mericans compared with Caucasians. Others have shown
hat risk-adjusted CABG outcomes in African Americans
nd Caucasians are similar, or that even when significantly
ifferent, the absolute differences in outcomes are small (i.e.,
ot clinically significant) and should not affect the decision
f whether to offer the surgery to patients (11–14).
The primary goal of our study was to compare operative
s well as 0- to 12-year mortality in African-American
ersus Caucasian patients in a contemporaneous U.S.
ABG series, and to do so in a manner in which potential
esidual confounding attributable to demographic and clin-
cal risk factors is minimized, in addition to that of medical
nsurance coverage. The latter was included given the
ocumented differences in the distribution of health cover-
ge among the ethnic groups (14,15) and their correlation to
ocioeconomic status, which is linked to worse CABG
utcomes (16). Accordingly, we analyzed a 13-year single-
nstitution CABG experience with long-term mortality
ollow-up. The reported analyses incorporated multiple
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October 18, 2005:1526–35 Role of Race in CABG Outcomesultivariate modeling methods including propensity score-
alancing techniques applied in all patients. Lastly, results
ere further assessed in one-to-one propensity-matched
thnicity-based cohorts.
ETHODS
atients. Study patients were drawn from 6,571 consecu-
ive and unique isolated CABG patients, including those
ndergoing repeat procedures, between June 1991 and
eptember 2003 at St. Vincent Mercy Medical Center
Toledo, Ohio), an urban community hospital. Only the
nitial CABG was included if the same patient underwent
ultiple CABG operations during the study period. Pa-
ients with concomitant carotid surgery were excluded, as
ere patients without a valid Social Security number.
ardiopulmonary bypass (normothermic with cold blood
ardioplegia) was used in 95% of patients, whereas the
emaining procedures were performed off-pump. This ob-
ervational study was approved by the institutional review
oard. Because of its retrospective nature, requirement for
nformed consent was waived.
linical data and end points. Clinical data on patients
ndergoing revascularization have been systematically ab-
tracted and prospectively collected in the cardiac surgery
linical database since June 1991, and are regularly reported
o the Society of Thoracic Surgeons (STS) national cardiac
urgery database. These include demographics, insurance,
isk factors and comorbidities, preoperative medications,
nd operative data, as well as postoperative complications
nd outcomes. Detailed insurance information, including
rimary and secondary insurance payors, was derived from
ospital and cardiac surgery billing records. The primary
nd points were all-cause operative mortality (OM) (defined
s 30-day or in-hospital, whichever was longer) and 0- to
2-year mortality. Long-term survival data were also col-
ected by service follow-up and searches of the U.S. Social
ecurity Death Index database (September 2004). Allowing
or a three-month lag, this corresponds to a follow-up of
etween 9 and 157 months.
tatistical methods. Continuous data were expressed as
ean  standard deviation. Univariate comparisons were
one with the chi-square test for categorical variables and
he unpaired t test (e.g., age, perfusion time) or the
on-parametric Mann-Whitney rank-sum test (e.g., num-
Abbreviations and Acronyms
CABG  coronary artery bypass surgery
CAD  coronary artery disease
CPB  cardiopulmonary bypass
HR  hazard ratio
OM  operative mortality
OR  odds ratio
STS  Society of Thoracic Surgeons
VHA  Veterans Health Administrationer of grafts) for continuous variables based on the normal- cty (Kolmogorov-Smirnov test) of the data. A p  0.05
utoff was used to indicate significance. Long-term Kaplan-
eier survival trends for the African-American and Cau-
asian cohorts were compared with (Breslow test) and
ithout (log rank test) weighting. The number of patients at
isk at a given time point was used for weighting. Effects of
xplanatory variables on OM were derived by logistic
egression. Next, multivariable Cox proportional-hazard
egression was done to assess the effects of the varying death
azard on long-term mortality predictors and their associ-
ted hazard ratios (HR). Three variables related to cardio-
ulmonary bypass duration were used: 1) aortic cross-clamp
ime (continuous), which indicates time used for graft
lacement; 2) off-pump CABG (categorical; yes  1 , no 
); and 3) difficult to wean off of cardiopulmonary bypass
CPB), defined as the difference between total CPB time 
ross-clamp time (categorical; yes  1 , no  0). Selection
f the logistic and Cox multivariable regression models was:
) done with backward elimination (Wald statistic, con-
rmed using forward and stepwise selection), and 2) con-
idered first-order interactions between variables that were
nivariately associated with race (Table 1). A p  0.05
ignificance level was used for model inclusion and p  0.1
or exclusion (SPSS version 10.0, SPSS Inc., Chicago,
llinois).
ropensity modeling and matching. Potential confound-
ng caused by the unbalanced characteristics of African-
merican versus Caucasian patients on outcome compari-
ons cannot be discounted, even after conventional
ultivariate risk adjustment (17,18). We used multiple
pproaches to minimize these effects. First, we computed
wo African-American propensity scores derived via: 1) a
arsimonious (only variables significant at the p 0.05 level
re included) and 2) a non-parsimonious (variables included
rrespective of significance) logistic regression models ap-
lied to all patients (African Americans  1, Caucasians 
). Excluding race, a comprehensive list of all STS required
atient variables (including those listed in Table 1) and their
ignificant interactions were considered for inclusion (par-
imonious) or included (non-parsimonious) in these logistic
egression models. Highly redundant variables were
voided. Year of surgery (1991 to 2003 coded as 1 to 13,
espectively) was entered to account for increasing frequency
f African-American patients over the study period. Pro-
ensity scores were used in two ways: 1) incorporated into
ubsequent multivariate model analyses as a continuous
ovariate (propensity-adjusted), or 2) to obtain one-to-one
atching of African-American scores with their closest
nique Caucasian match via a custom-made computer
lgorithm that allowed a maximum 1% score difference
propensity matching). Patient variables and risk factors for
he propensity-matched cohorts are checked for differences,
nd will typically approximate random samples of similar
haracteristics.
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Role of Race in CABG Outcomes October 18, 2005:1526–35ESULTS
emographics, baseline characteristics, and operative
ariables. The patient series included 6,073 Caucasian
92.4%), 304 African-American (4.6%), and 194 other
thnicity (109 Hispanic) patients. The proportion of Cau-
asian patients decreased from approximately 94% (early
0s) to around 90% (2001 to 2003) over the study period,
able 1. Comparison of Selected Preoperative and Operative Dat
AA) and Caucasian CABG Patients
All Patients
Caucasian AA
atients, n 6,073 304
ale, % 70.2 53.9
ge (yrs) 64  11 62  11
SA (m2) 2.02  0.24 2.00  0.
bese (BMI 30 kg/m2), % 38.3 41.8
rivate insurance, % 48.1 41.1
edicare, % 46.9 42.4
ny Medicaid, % 6.3 28.6
ninsured, % 1.4 3.3
urrent smoker, % 21.7 35.5
iabetes, % 32.4 43.4
Insulin-dependent, % 11.6 22.4
igh cholesterol, % 65.8 61.5
enal failure (pre-operative), % 3.0 7.9
ypertension, % 80.0 92.8
erebrovascular accident, % 7.0 10.5
hronic lung disease, % 20.3 18.8
eripheral vascular disease, % 13.8 21.4
erebrovascular disease, % 21.2 22.0
reoperative MI, % 58.2 64.1
ongestive heart failure, % 10.3 15.3
nstable angina, % 38.0 35.2
rrhythmia (any), % 15.0 11.2
ouble vessel disease, % 23.0 22.0
riple vessel disease, % 71.7 73.4
eft main disease 50%, % 19.0 18.4
jection fraction (%) 50  11 49  12
YHA functional class III, % 45.4 44.1
YHA functional class IV, % 38.9 41.4
reoperative IABP, % 6.7 4.9
revious CV intervention, % 36.0 28.9
eta-blockers, % 57.7 67.4
perative data
Repeat CABG, % 4.9 4.3
Urgent, % 51.1 56.3
Emergent, % 6.9 4.9
No. of grafts 3.1  1.0 3.0  0.
Vein 1.8  1.0 1.8  1.
Arterial 1.3  0.8 1.3  0.
Radial used, % 25.6 26.6
IMA used, % 89.3 87.8
LIMA, % 87.9 86.8
Off-pump CABG, % 4.6 7.6
Cross-clamp time (min) 48  18 47  17
Perfusion time (min) 84  32 82  34
Day of surgery* 2,235  1,206 2,589  1,
n expanded Table 1 (Table S1) is included in the online version of this article. Contin
f grafts (vein/arterial), by rank sum test. Categorical variables were compared by ch
BMI  body mass index; BSA  body surface area; CABG  coronary artery
ammary artery; LIMA  left IMA; MI  myocardial infarction.hereas African Americans doubled from 4% (early 90s) Np to approximately 8% in 2002 to 2003 (Fig. 1). The 2000
o 2003 statistics at our institution show that hospital
ischarges were 71.4%, 23.4%, and 5.2% for Caucasian,
frican-American, and Hispanic/other, respectively. The
orresponding cardiac surgery discharges were 86.5%, 7.9%,
nd 5.5%. The latter closely approximated the race distri-
ution (87.6%, 6.9%, and 5.5%, respectively) for the 20
Unmatched (All Patients) and Matched African-American
Matched
p Caucasian AA p
– 301 301 –
0.001 58.8 54.5 NS
0.001 61.4  10.7 61.7  10.3 NS
NS 2.00  0.25 2.00  0.23 NS
NS 41.9 41.2 NS
0.017 35.5 41.5 0.13
0.13 45.2 42.9 NS
0.001 29.2 27.9 NS
NS 5.3 3.3 NS
0.001 39.2 35.2 NS
0.001 39.2 42.9 NS
0.001 21.9 21.9 NS
0.001 67.4 61.1 0.13
0.001 8.3 7.6 NS
0.001 90.7 92.7 NS
0.020 7.6 10.3 NS
NS 20.3 18.3 NS
0.001 19.6 21.6 NS
NS 25.9 21.9 NS
0.039 58.8 64.8 0.13
0.006 13.3 15.1 NS
NS 37.2 35.2 NS
0.067 10.3 11.0 NS
NS 24.9 22.3 NS
NS 70.4 73.4 NS
NS 18.3 18.3 NS
NS 50  11 49  12 NS
NS 47.8 44.5 NS
NS 39.2 41.5 NS
NS 5.6 5.0 NS
0.013 25.9 29.2 NS
0.001 60.8 67.1 0.11
NS 2.7 4.3 NS
0.080 58.8 56.1 NS
0.19 6.6 5.0 NS
NS 3.0  0.9 3.0  0.9 NS
NS 1.8  1.0 1.8  1.0 NS
NS 1.2  0.7 1.2  0.7 NS
NS 25.2 26.6 NS
NS 90.4 87.7 NS
NS 90.0 86.7 NS
0.019 5.6 7.3 NS
0.041 46  17 47  17 NS
0.045 80  28 82  34 NS
0.001 2,431  1,143 2,577  1,236 NS
ata (shown as mean standard deviation) were compared by t test except for number
re test; NS  p  0.2. Day of surgery assumes June 4, 1991  1.
s graft; CV  cardiovascular; IABP  intraaortic balloon pump; IMA  internala in
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October 18, 2005:1526–35 Role of Race in CABG Outcomesrea (87.6%, 6.9%, and 5.5%, respectively). Heretofore, we
ill only report on the Caucasian and African-American
ohorts.
Demographic, comorbidity, and operative data for the
frican-American and Caucasian cohorts are compared in
able 1. Briefly, African Americans were younger (62 vs. 64
ears [mean]), were more female (46% vs. 30%), were more
urrent smokers (35.5% vs. 21.7%), and were characterized
y a greater incidence of insulin dependence, hypertension,
reoperative renal failure, history of cerebrovascular acci-
ent, peripheral vascular disease, congestive heart failure,
nd prior myocardial infarction. Vessel disease and func-
ional class were similar for the two groups. Notably,
edicaid status was more than four-fold greater among
frican Americans [28.6 vs. 6.3%; p  0.001]. Also, a
ubstantial increase in Medicaid coverage (primary or sec-
ndary) was observed, from 5% in 1991 up to 11% in 2003,
hich paralleled the increase in African Americans (Fig. 1).
A greater fraction of Caucasians had a history of prior
ardiovascular intervention (36% vs. 29%) but not previous
ABG (4.9% vs. 4.3%; all must have occurred before June
991 by study design). Operative data, including number
nd type of grafting conduits, were mostly similar for the
igure 1. (Top) Annual distribution of Caucasian, African-American, and
ispanic/Other coronary artery bypass grafting (CABG) patients at Saint
incent Mercy Medical Center between 1991 and 2003. (Bottom) Annual
istribution of Medicare, Medicaid, private insurance, and uninsured
mong CABG patients at Saint Vincent Mercy Medical Center between
991 and 2003.wo groups (Table 1). There were trends for more frequent (rgent status among African Americans (56% vs. 51%; p 
.08), and off-pump CABG was slightly more frequent
7.6% vs. 4.9%; p 0.02) in African-American patients. To
ccount for potential confounding effects of race group
ifferences, we derived parsimonious and non-parsimonious
ropensity score models via logistic regression analysis. The
esults are very similar with both models, and only the
arsimonious model results are described. The median
interquartile range) parsimonious model propensity score
as 0.064 (0.035 to 0.145) in African Americans, compared
ith 0.033 (0.021 to 0.050) for Caucasians. The C-statistic
area under the receiver-operator characteristic curve or
UC) for the propensity score model was 0.74, indicating
ood discrimination power. Given the abundance of Cau-
asian patients, we were able to match to within a 1% score
ifference 301 of 304 (parsimonious; 99%) and 296 of 304
non-parsimonious; 97%) African-American patients. The
atched groups had similar demographics, medical cover-
ge, risk factors, coronary disease, and operative variables
Table 1).
omparison of CABG outcomes. OPERATIVE RESULTS.
perative outcomes are compared in Table 2. Briefly, for
he entire cohorts, African Americans were more frequently
ransfused (37.2% vs. 28.3%, p  0.001), had a greater
ncidence of postoperative sepsis (3.3% vs. 1.4%; p 
.006), and required an average of one day longer postop-
rative hospital stay (8.0 vs. 7.0; p  0.006). We also
bserved, in African Americans, trends for: 1) more bleed-
ng complications requiring chest re-exploration (3.0% vs.
.6%; p  0.07), 2) more vein harvest site leg infection
2.0% vs. 0.9%; p  0.08), and 3) less new-onset postop-
rative atrial fibrillation (12.2% vs. 16.0%; p  0.07). All
ther postoperative complications occurred with similar
requency for the two groups. Operative mortality was
imilar in African-American (9 of 304; 3.0%) and Caucasian
152 of 6,073; 2.5%) patients (unadjusted odds ratio [OR]
1.18; p  0.61). For matched groups (Table 2), operative
ortality was also similar (3.0% vs. 2.7%; unadjusted OR 
.13), as were all complication rates and resource use. Older
ge, emergency or repeat CABG, difficulty to wean off
ypass, preoperative renal failure, small body size, conges-
ive heart failure, cerebrovascular disease, history of myo-
ardial infarction, and morbid obesity were identified as
ultivariate predictors of operative death (Table S2, please
ee the online version of this article). This model was both
eliable (Hosmer-Lemeshow chi-square statistic  8.17; p
0.42) and accurate (AUC  0.83). Forcing race (OR 
.17 [95% confidence interval (CI) 0.55 to 2.50]) into this
odel did not improve model reliability (p  0.70) or
ccuracy (AUC  0.84).
ATE RESULTS. Follow-up was longer for Caucasians
2,214  1,246 vs. 1,815  1,229 days; p  0.001) because
relatively larger fraction of African-American patients had
ndergone CABG in recent years. A total of 1,241 deaths
161 operative, 1,080 late) have been documented. The
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Role of Race in CABG Outcomes October 18, 2005:1526–35nadjusted Kaplan-Meier survival was significantly worse
or African Americans (Fig. 2; HR  1.38 [95% CI 1.08 to
.76]; p  0.004) with worse survival rates at 1, 5, and 10
ears in African Americans (93.4%, 80.3%, and 66.1%)
ersus Caucasians (94.8%, 86.5%, and 71.7%). These sur-
ival differences were true for patients 65 years old (p 
.012) and 65 years old (p  0.028), but were less
ronounced in women (p  0.25) versus men (p  0.011),
articularly during the first two years (Fig. S1, please see the
nline version of this article).
Using race and propensity score as the only covariates in
he Cox regression analysis, we found the African-American
ropensity score (p  0.0001) to be a predictor of 0- to
2-year mortality, whereas race was not (HR  1.15 [95%
I 0.89 to 1.49]; p  0.28 [parsimonious]). The corre-
ponding propensity-adjusted 0- to 12-year CABG survival
omparisons are shown in Figure 3. These results were
onsistent with the Kaplan-Meier survival analysis of the
atched groups (Fig. 3). The latter indicated that when
losely matched for preoperative, including medical health
overage, and operative factors, late CABG survival is
ssentially identical in both ethnic groups (HR 1.03 [95%
I 0.74 to 1.44]; p  0.97). With the propensity score
ncluded as a model covariate (HR  1.04 [95% CI 0.19 to
.59]; p  0.97), we identified 20 multivariate predictors of
ong-term mortality (Table 3). Here, too, entering race as a
ovariate did not significantly improve the model (HR 
.19 [95% CI 0.92 to 1.53]; p 0.19). Briefly, survival after
ABG was superior in patients with a history of preoper-
tive beta-blocker use. Alternatively, risk factors predicting
able 2. Comparison of Operative Outcome Data in Unmatched
ABG Patients
All Patients
Caucasian AA
lood transfusion, % 28.3 37.2
erioperative IABP, % 3.6 2.6
omplication (any), % 30.6 34.9
eoperation (any), % 6.6 5.8
eoperation (bleeding), % 1.6 3.0
erioperative MI, % 1.2 1.3
trial fibrillation, % 16.0 12.2
ediastinitis, % 1.2 1.0
eg infection, % 0.9 2.0
epsis, % 1.4 3.3
ermanent stroke, % 1.3 2.3
ransient stroke, % 1.9 2.3
entilator prolonged 24 h, % 6.5 7.9
neumonia, % 1.8 2.0
enal failure, % 4.0 4.6
I complications, % 2.7 3.3
ulti-organ failure, % 1.3 1.6
otal LOS (days) 9.0  8.2 11  10
ostoperative LOS (days) 7.0  7.6 8.0  8.9
0-day hospital readmission, % 6.4 5.9
perative mortality, % 2.5 3.0
Continuous data (mean  std dev) were compared by t test or rank sum test and c
Abbreviations as in Table 1.(All Patients) and Matched African-American (AA) and Caucasian
Matched
p Caucasian AA p
0.001 35.9 37.2 0.74
0.24 4.0 2.7 0.36
0.12 32.6 34.9 0.55
0.66 8.3 6.3 0.43
0.07 1.3 3.0 0.16
0.30 1.0 1.3 0.70
0.07 14.6 12.0 0.34
0.73 1.7 1.0 0.48
0.08 2.3 2.0 0.78
0.006 3.3 3.3 1.0
0.14 1.0 2.3 0.20
0.59 0.7 2.3 0.10
0.34 8.0 8.0 1.0
0.84 4.3 2.0 0.10
0.61 3.7 4.7 0.54
0.50 3.3 3.3 1.0
0.54 1.3 1.7 0.74
0.001 10.0  12.2 11.3  10.0 0.16
0.006 7.9  11.8 8.2  8.9 0.72
0.75 7.6 6.0 0.42
0.61 2.7 3.0 0.81ncreased 12-year mortality were older age, Medicaid status,
s
higure 2. Overall unadjusted Kaplan-Meier 0- to 12-year survival in
frican-American (AA) (thick lines) versus Caucasian (thin line) coro-
ary artery bypass graft (CABG) patients (patient characteristics are
ummarized in Table 1). Hazard ratio is calculated from Cox proportional
azard regression with race as a single covariate.
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October 18, 2005:1526–35 Role of Race in CABG Outcomesenal failure, diabetes, current smokers, difficulty to wean off
PB, vein-only grafts, low ejection fraction, preoperative
iuretics, triple vessel disease, male gender, cerebrovascular
isease, peripheral vascular disease, small patient size, emer-
ency surgery, arrhythmia, congestive heart failure, prior
igure 3. (Left) Propensity-adjusted survival derived by proportional haza
ncluded as covariates. Dashed line  survival at mean of covariates. (Rig
n matched African-American (AA) (thick lines) versus Caucasian (thin
dentical (see Fig. S2 of the online version of this article).
Table 3. Multivariate Predictors of 0- to 12-Y
Applied in All Patients
Variable
Wald
(Chi-Squar
Age (per 10-yr increments) 216.8
Renal failure 82.5
Diabetes
No 54.9
Yes (no insulin) 10.9
Yes (insulin) 53.5
Current smoker 28.4
Difficulty to wean off CPB 26.0
Vein-only grafts 23.6
Ejection fraction
40% 19.8
26% to 40% 13.8
25% 9.5
Preoperative diuretics 19.7
Triple vessel disease 15.1
Men 13.5
Cerebrovascular disease 12.4
Peripheral vascular disease 11.6
Preoperative beta-blockers 10.7
Low BSA (1.7 m2) 9.5
Emergency 9.1
Medicaid status 8.0
Arrhythmia 6.4
Congestive heart failure 4.8
Prior cardiovascular intervention 4.4
Hypertension* 3.7
AA propensity score (forced) 0.0
AA (forced into model) 1.7*Approached significance.
AA  African American; BSA  body surface area; CPB  cardiovascular intervention, and hypertension (see Table 3
or details).
edicaid status and late CABG outcomes. Race did not
redict CABG outcomes, but Medicaid status, which is
ore than four-fold more frequent among African Ameri-
x regression analysis with race and propensity score (parsimonious model)
aplan-Meier 0- to 12-year coronary artery bypass graft (CABG) survival
patients. Corresponding non-parsimonious model results were essentially
ortality Derived by Cox Regression Analysis
p Value
Hazard
Ratio
95%
Confidence
Interval
0.0000 1.54 1.46–1.61
0.0000 2.80 2.24–3.50
0.0000 1 (reference)
0.0009 1.27 1.10–1.46
0.0000 1.83 1.56–2.16
0.0000 1.51 1.30–1.76
0.0000 1.58 1.32–1.88
0.0000 1.48 1.26–1.73
0.0000 1 (reference)
0.0002 1.37 1.16–1.61
0.0020 1.50 1.16–1.93
0.0000 1.36 1.19–1.56
0.0001 1.32 1.15–1.53
0.0002 1.33 1.14–1.55
0.0004 1.27 1.11–1.45
0.0007 1.30 1.12–1.51
0.0011 0.82 0.73–0.93
0.0020 1.37 1.12–1.68
0.0026 1.37 1.12–1.68
0.0047 1.54 1.14–2.08
0.0117 1.20 1.04–1.38
0.0290 1.22 1.02–1.45
0.0363 1.14 1.01–1.29
0.0549 1.17 1.00–1.37
0.9657 1.04 0.19–5.59
0.1931 1.19 0.92–1.53rd Co
ht) K
line)ear M
ed)ardiopulmonary bypass.
c
p
C
i
n
[
M
a
[
4
1
t
fi
d
n
p
s
m
a
M
C
(
M
0
2
o
r
i
s
D
M
e
d
a
c
(
f
e
c
c
i
F
l
n
l
p
T (blac
d ce in
1532 Zacharias et al. JACC Vol. 46, No. 8, 2005
Role of Race in CABG Outcomes October 18, 2005:1526–35ans, did with a 54% greater 12-year mortality (HR  1.54;
 0.0047). We thus assessed, post hoc, this Medicaid-
ABG outcome association by comparing survival in Med-
caid (n  469; 235 men [50%], 60 years [median]) vs.
on-Medicaid (n  5,908; 4,191 men [71%], 65 years
median]) patients. Comparisons were also repeated for
edicare (n  2,979 [207 Medicaid], 71 years [median])
nd non-Medicare (n  3,398 [262 on Medicaid], 57 years
median]) cohorts. These results are summarized in Figure
and Table 4. Briefly, for all patients, the unadjusted 0- to
2-year mortality was significantly worse in Medicaid pa-
ients (HR  1.61; p  0.0001) despite being an average of
ve years younger. This worse unadjusted Medicaid survival
ifference was particularly pronounced in the younger,
on-Medicare sub-cohort (HR  2.32; p  0.0001) com-
ared with a much smaller difference in the Medicare
ub-cohort (HR  1.28; p  0.06). Covariate risk adjust-
ent confirmed these findings, as did the Kaplan-Meier
nalysis in closely matched cohorts (Fig. 3, Table 4).
oreover, the propensity-matched analyses showed that
ABG survival data exhibits time-varying death hazard
igure 4. (Top left) Unadjusted 0- to 12-year Kaplan-Meier (K-M) surv
ine) coronary artery bypass graft (CABG) patients. (Top middle) P
on-Medicaid (thin line) CABG patients with additional Medicare covera
ine) versus non-Medicaid (thin line) CABG non-Medicare patients. (B
ropensity-matched Medicaid (thick line) versus non-Medicaid (thin lin
en-year relative death hazard functions (Medicaid yes/no) for all patients
erived from analyses of propensity-matched survival data. CI  confiden19) over time where: 1) in older Medicare patients, qedicaid status did not increase mortality (HR 1.20; p
.33) with only a limited early association (1 to 2 years), and
) in the younger non-Medicare patients, the Medicaid-
nly coverage was associated with nearly twice the mortality
isk (HR  1.96; p  0.003), which is primarily character-
zed by a systematically increasing death hazard after the
econd post-CABG year.
ISCUSSION
ain findings. The objective of this investigation was to
lucidate whether operative and long-term outcomes are
ifferent for African-American versus Caucasian patients
nd, if yes, how. Our African-American and Caucasian
ohorts showed substantially different patient characteristics
Table 1), including age, gender, and multiple comorbid risk
actors. Yet, importantly, operative CABG variables were
ssentially identical, including arterial/vein grafting and
ardiopulmonary bypass. This 1991 to 2003 series was also
haracterized by: 1) race-dependent distribution of medical
nsurance payors with a disproportionate Medicaid fre-
unmatched Medicaid (triangles, thick line) versus non-Medicaid (thin
sity-adjusted comparison of survival in Medicaid (thick line) versus
op right) Propensity-adjusted comparison of survival in Medicaid (thick
m left) Unadjusted 0- to 12-year Kaplan-Meier survival in one-to-one
BG patients: Medicare (black), non-Medicare (gray). (Bottom Right)
k, thin), Medicare cohort (black, thick), and non-Medicare cohort (gray)
terval.ival in
ropen
ge. (T
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October 18, 2005:1526–35 Role of Race in CABG Outcomesoncurrent parallel trends of increasing number of African-
merican and Medicaid patients over the study period. The
atter may reflect a trend toward a more equitable referral of
atients for CABG. However, it also raises the potential of
nteraction between two factors with implications on
ABG outcomes: ethnicity and insurance payor.
Early outcomes showed that African Americans exhibit
ignificantly worse unadjusted postoperative morbidity
complications) and are associated with greater resource use
transfusions, hospital stays). This result in an urban com-
unity hospital series is similar to that reported by Rums-
eld et al. (13) in the Veterans Health Administration
VHA) system nationwide (1995 to 2001; n  33,428). We
lso found a small absolute (non-significant) difference in
nadjusted operative mortality (OM) (3.0% vs. 2.5%), but
ace was not a predictor of OM by multivariate regression.
ridges et al. (5) analyzed the 1994 to 1997 STS national
atabase and showed that African Americans are associated
ith a small yet significant increase in OM after risk
djustment (3.83% vs. 3.14%). A similar finding from the
TS was reported by Hartz et al. (6). In matched patients,
e report similar complication rates, resource use, and OM
Table 2). This result agrees with results from Higgins et al.,
12) who found a substantial difference in unadjusted OM
5.5% African-Americans vs. 2.5% Caucasians), but this was
xplained by the imbalance in risk factors and co-morbidity.
lso, like us, they reported more Medicaid status among
frican Americans, but this did not affect operative out-
omes (12).
In our series, the unadjusted 12-year CABG mortality
as significantly worse for African Americans (Fig. 1).
owever, multiple multivariate analyses converged showing
hat this difference in survival is explained by the imbalance
Table 4. Medicaid Status as a Predictor of 0-
6,377 at Saint Vincent Mercy Medical Center
Model
Medica
N (Yes/
All patients (n  6,377)
Unadjusted 469/5,9
Age-adjusted 469/5,9
Covariate-adjusted* 469/5,9
Matched patients† 449/44
Medicare patients (n  2,979)
Unadjusted 207/2,7
Age-adjusted 207/2,7
Covariate-adjusted* 207/2,7
Matched patients† 193/19
Non-Medicare patients (n  3,398)
Unadjusted 262/3,1
Age-adjusted 262/3,1
Covariate-adjusted* 262/3,1
Matched patients† 256/25
*Covariate adjustment was achieved via a propensity score (M
race (African American: yes  1/no  0). †Patients were on
(yes  1/no  0) propensity score models: 1 for Medicare
(C-index  0.845).f clinical risk factors in addition to Medicaid coverage among the two groups and not race per se (Tables 3 and 4).
his was also consistent with the essentially identical
aplan-Meier survival results irrespective of race in
atched patients (Fig. 2).
Other studies have explored the relationship between race
nd long-term CABG outcomes with non-uniform find-
ngs. In 1997, Taylor et al. (7) reported that 16-year survival
as significantly worse in African Americans versus Cau-
asians for the 1970s Coronary Artery Surgery Study
CASS), and survival differences were more pronounced in
ABG-treated versus medically treated patients. An earlier
ASS analysis (10) reported that age- and gender-adjusted
ve-year survival was only worse in medically treated
frican-American patients. Both studies showed a substan-
ial adverse effect of current smoking status (more prevalent
n African Americans) on long-term outcomes (7,10).
nfortunately, nearly two decades later, we also found a
reater propensity for current smoker status among African
mericans (35.5% vs. 21.7%), which independently in-
reased 0- to 12-year mortality (HR  1.51). In a review of
2,402 CAD patients (10.3% African Americans) who
nderwent angiography at Duke University (1984 to 1992),
eterson et al. (1) reported that African Americans were
ignificantly less likely to undergo coronary revascularization
particularly CABG), and this difference could not be
xplained by clinical factors or coronary disease character-
stics. Then, given the significantly worse five-year survival
n African-American patients (unadjusted HR  1.41), the
nvestigators concluded that revascularization (CABG or
ngioplasty) was underused in African Americans. Note,
hen adjusted to prognostic factors and treatment, the
ifference in survival was only marginally higher in African
mericans (HR  1.08 [95% CI 0.97 to 1.20]) (1). In
-Year Survival After Isolated CABG in
edo, Ohio, 1991 to 2003)
Hazard
Ratio
95%
Confidence
Interval p Value
1.61 (1.33–1.95) 0.0001
2.07 (1.71–2.50) 0.0001
1.46 (1.19–1.80) 0.0003
1.47 (1.11–1.95) 0.008
1.28 (0.99–1.66) 0.06
1.62 (1.25–2.11) 0.0003
1.31 (0.97–1.75) 0.075
1.20 (0.83–1.75) 0.33
2.32 (1.75–3.09) 0.0001
2.66 (2.00–3.55) 0.0001
1.92 (1.41–2.62) 0.0001
1.96 (1.25–3.05) 0.003
d: yes  1, no  0) based on variables in Table 1, including
ne matched (greedy) using two non-parsimonious Medicaid
ts (C-index  0.811) and one for non-Medicare patientsto 12
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Role of Race in CABG Outcomes October 18, 2005:1526–35isk of death within the first five years after CABG in
frican Americans was twice that in Caucasian patients.
rooks et al for the Bypass Angioplasty Revascularization
nvestigation (BARI) randomized trial reported increased
ve-year all-cause mortality in African-American patients
HR  1.49), and they did not find a significant race and
reatment (angioplasty or CABG) interaction effect on
urvival (9).
In the VHA setting, Maynard and Ritchie (11) reported
hat for veterans undergoing CABG at 44 medical centers
1994 to 1999), five-year survival was slightly (87% vs. 89%)
et significantly worse in African Americans (HR  1.09).
his analysis, like most VHA analyses, was limited by its
eliance on administrative databases that do not allow for
omprehensive risk adjustment (20–22). Alternatively, in
nother VHA analysis in which a more comprehensive
linical database was available, Rumsfeld et al. (13) reported
imilar six-month CABG mortality in African Americans
nd Caucasians (adjusted OR  1.10; p  0.31). Both
tudies concluded that ethnicity was not a strong risk factor
or adverse outcomes after CABG. Importantly, VHA
esults are uniquely characterized by similarity of access to
ealth care services irrespective of ethnicity both before and
fter CABG. This characteristic is not true of the general
on-veteran U.S. population such as ours, and hence the
pplicability of these findings is unclear (20,21).
Our data do not implicate race as a predictor of early or
ate CABG outcomes. However, we report that Medicaid
tatus, which is more prevalent among African Americans,
s independently associated with worse long-term survival
HR  1.54 overall and 1.96 non-Medicare). To our
nowledge, such a strong adverse Medicaid status-long-
erm CABG outcome association has not been described.
edicaid-funded care is unlikely to be a causal risk factor
or worse CABG outcomes, particularly because early or
perative outcomes did not vary with Medicaid status.
owever, it is arguably possible that certain re-engineering
f Medicaid care promoting more physician follow-up and
ccess to risk-modification programs (cardiac rehabilitation)
ay impact long-term outcomes favorably (23,24). This
ontention is advanced by the fact that the observed late
urvival-Medicaid association is largely mitigated in patients
ith the additional Medicare coverage (Fig. 3).
Alternatively, Medicaid is clearly a risk marker of lower
ocioeconomic status, which can impact long-term CABG
utcomes in ways that are independent of the Medicaid
ystem. Low socioeconomic status is a marker of poverty,
ow educational levels, poor health habits, unemployment,
ifelong stress, and fewer opportunities. These can translate
o lack of adequate adherence to prescribed medications and
nhealthy diets, which are associated with poorer outcomes
15,16,23,24).
tudy limitations. This study is an observational single-
enter investigation performed on patients derived from a
rospectively collected comprehensive clinical database. It is
ot possible to prospectively randomize patient race with oABG. Fortunately, advances in statistical methods have
vercome many of the known shortcomings of observational
ata analyses (17–19). If used properly, these methods may
dequately answer important clinical questions. Here, we
oncomitantly used multiple methods to better corroborate
ur findings: conventional risk adjustment, propensity ad-
ustment, and balanced scores (or matched) cohorts based
n the propensity models. The latter approach successfully
dentified closely matched African-American and Caucasian
atients as well as Medicaid and non-Medicaid patient
roups. Convergence of all of these analyses significantly
dvances our main finding that ethnicity is not an indepen-
ent predictor of outcomes, whereas Medicaid status is.
hat said, a potential impact of unmeasured confounding
ariables on the propensity matching remains a possibility
18), but the comprehensiveness of the propensity models
inimizes this possibility. Second, our results are limited by
he fact that we only report all-cause mortality. Third, we
sed the social security death index to validate our service
ong-term follow-up, which is not necessarily 100% accu-
ate. This, however, is not expected to be race-dependent
nd should not bias our findings. Fourth, other than the
ossibility of late referral to CABG of African American
atients, we could not fully explain their substantially
reater incidence of preoperative co-morbid compared with
he older Caucasian group. In this study, we could not
valuate any potential race association/bias before the
ABG surgery (e.g., referral to catheterization). Lastly, our
nalysis was also limited by our inability to fully elucidate
hat is it about Medicaid patients (at time of CABG) that
eads to the substantially worse late outcomes, and how.
atient educational level, household income, and other
elated socioeconomic data were not available to us. Further,
eople often move in and out of Medicaid coverage. The
ength and continuity of Medicaid coverage, in addition to
he possibility of adjunct coverage other than Medicare,
ere also not available to us.
ONCLUSIONS
frican-American race per se is not associated with worse
perative or late CABG outcomes, which underscores the
act that CABG surgery should be offered based strictly on
linical characteristics and irrespective of race. Alternatively,
edicaid status, which is substantially more prevalent
mong African Americans and other minority groups, was
ndependently associated with worse late survival, especially
n younger patients who lack the additional Medicare
overage. Because of the potentially large social implications
f these data, we suggest the need for wider national-scale
tudies to address the suboptimal late CABG results in
edicaid patients focusing on the adequacy of post-CABG
ongitudinal care, cardiac risk modification, and the multiple
ther socioeconomic factors with implications on outcomes.
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